An alpha-synuclein MRM assay with diagnostic potential for Parkinson’s disease and monitoring disease progression

AIM: The alpha-synuclein (α-syn) level in human cerebrospinal fluid (CSF), as measured by immunoassays, is promising as a Parkinson’s disease (PD) biomarker. However, the levels of total α-syn are inconsistent among studies with large cohorts and different measurement platforms. Total α-syn level al...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Proteomics Clin Appl
Autori principali: Yang, Li, Stewart, Tessandra, Shi, Min, Pottiez, Gwenael, Dator, Romel, Wu, Rui, Aro, Patrick, Schuster, Robert J., Ginghina, Carmen, Pan, Catherine, Gao, Yuqian, Qian, Weijun, Zabetian, Cyrus P., Hu, Shu-Ching, Quinn, Joseph F., Zhang, Jing
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5540649/
https://ncbi.nlm.nih.gov/pubmed/28319654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prca.201700045
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi